Prevail Therapeutics Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Prevail Therapeutics Inc.
CIK #0001714798
EDGAR Form CIK 2011 - 2024
10-K [0001714798]
10-Q [0001714798]
3 [0001714798]
4 [0001714798]
8-K [0001714798]
D [0001714798]
SC 13D [0001714798]
SC 13G [0001714798]
Form 13D/13G Filer Form 13D/13G Subject Filed
JNE Partners LLP Prevail Therapeutics Inc [2021-01-29]
Eli Lilly & Co Prevail Therapeutics Inc [2020-12-22]
Citadel Advisors LLC Prevail Therapeutics Inc [2020-10-08]
RA Capital Management LP Prevail Therapeutics Inc [2020-02-14]
Abeliovich ASA Prevail Therapeutics Inc [2020-02-13]
REGENXBIO Inc Prevail Therapeutics Inc [2020-02-13]
EcoR1 Capital LLC Prevail Therapeutics Inc [2019-06-28]
OrbiMed Advisors LLC Prevail Therapeutics Inc [2019-06-27]
Form 3/4/5 Subject 2011 - 2024
Dai Yong
Prevail Therapeutics Inc.
Nader Francois
Schwartz Kira M.
Sevigny Jeffrey
Sheng Morgan
Nussbaum Ran
Gordon Carl L
Thompson Peter A.
OrbiMed Advisors LLC
View All
Terms | Privacy | Guide
tony@aum13f.com